Drug
Calcifediol clinical trials
- studies test it
- 26
- open now
- 2
- in phase 3
- 6
- first study started
- 2009
Keep track of what changes. Save the Calcifediol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
26 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 3
- Phase 2
- 8
- Phase 3
- 6
- Phase 4
- 7
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 14
OPKO Health, Inc. (7) · OPKO IP Holdings II, Inc. (3) · Tehran University of Medical Sciences (2) · David Leaf (1) · Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1) · Faes Farma, S.A. (1) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (1) · University of California, Los Angeles (1)
Often tested with
Tested in the same studies.
Modified-release Calcifediol Capsule (8) · Cholecalciferol (6) · Calcitriol (1) · Vitamin D (1) · 25-hydroxyvitamin D (1) · Paricalcitol (1)
Studies
Open first, then newest update. How each study uses Calcifediol is read from its arms, and is right about nine times in ten.
Testing it · 26
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Evaluation of CTAP101 Extended-release Capsules in Pediatric ParticipantsRecruitingPhase 2OPKO Health, Inc.NCT07494045Written as CTAP101
- REstoration of VItamin D in Pulmonary Arterial HypertensionNot yet recruitingPhase 4Parc de Salut MarNCT06258850Written as Calcifediol Oral Capsule
- Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDITerminatedPhase 2OPKO Health, Inc.NCT03602261Written as Calcifediol Oral Capsule
- Activated Vitamin D for the Prevention and Treatment of Acute Kidney InjuryCompletedPhase 2David LeafNCT02962102Written as Calcifediol
- Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary HyperparathyroidismTerminatedPhase 3OPKO Health, Inc.NCT05543928Written as CTAP101
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedPhase 3OPKO IP Holdings II, Inc.NCT01651000Written as CTAP101 30 μg capsules
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedPhase 3OPKO IP Holdings II, Inc.NCT01704079Written as CTAP101 30 μg capsules
- Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19CompletedPhase 2OPKO Health, Inc.NCT04551911Written as Rayaldee
- Effect of Vitamin D on Ventricular Remodeling in Patients With Acute Myocardial Infarction (VITDAMI)CompletedPhase 3Instituto de Investigación Sanitaria de la Fundación Jiménez DíazNCT02548364Written as Calcifediol
- Efficacy and Safety of Calcifediol vs Placebo in Subjects With Vitamin D DeficiencyCompletedPhase 2/3Faes Farma, S.A.NCT04735926Written as Calcifediol 75mcg
- Vitamin D Supplementation on in Major Orthopedic SurgeryCompletedPhase 4I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioNCT03403933Written as Didrogyl
- Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D InsufficiencyCompletedPhase 4OPKO Health, Inc.NCT03588884Written as Calcifediol Oral Capsule
- Investigating the Effects of Hydroxyvitamin D3 on Multiple SclerosisStatus unknownPhase 4Tehran University of Medical SciencesNCT05340985Written as 25(OH)D3
- Effects of Vitamin D3 Versus 25OHD3 on Mineral Metabolism and Immune FunctionCompletedEarly Phase 1University of California, Los AngelesNCT02091219Written as 25(OH)D3
- The Effect of Supplementation of Vitamin D Deficiency in Older People With Acute Hip Fracture:CompletedPhase 4Leonor Cuadra LlopartNCT03213886Written as Calcifediol (Vitamin D)
- Oral 25-hydroxyvitamin D3 and COVID-19Status unknownPhase 2/3Tehran University of Medical SciencesNCT04386850Written as Oral 25-Hydroxyvitamin D3
- Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy SubjectsCompletedPhase 1OPKO Health, Inc.NCT03660800Written as CTAP101 Capsules
- Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic AcidCompletedPhase 1OPKO Health, Inc.NCT02274623Written as CTAP101 Capsules
- To Test the Effect of Calcifediol Hy.D Supplementation on Muscle Function and Bone Quality in Younger Postmenopausal Women With OsteopeniaCompletedPhase 2DSM Nutritional Products, Inc.NCT02527668Written as Calcifediol
- Efficacy of Calcifediol Supplementation in Asthma Control in Asthmatic Patients With Vitamin D Deficiency (ACViD)CompletedPhase 4MurciaSaludNCT02805907Written as Calcifediol
See all 26 studies that test Calcifediol →
Given in every arm · 2 — Calcifediol is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Calcifediol
Codes
What other systems call Calcifediol · ClinicalTrials.gg INT007113
- MeSH (NLM) D002112CalcifediolConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) P6YZ13C99QCALCIFEDIOLConfirmed FDA, NLM, Wikidata
- RxNorm 1889Confirmed FDA, Wikidata
- Wikidata Q27286305calcifediol monohydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65278CalcifediolOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002112 | Calcifediol | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | P6YZ13C99Q | CALCIFEDIOL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1889 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27286305 | calcifediol monohydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65278 | Calcifediol | One source FDA |
Also registered as calcifediol anhydrous (UNII T0WXW8F54E · RxNorm 1855064).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.